A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-α signal in vivo

作者: Shiro Tochizawa , Yasukazu Ohmoto , Toyoki Mori

DOI: 10.1016/J.JIM.2006.03.015

关键词:

摘要: Abstract Phosphorylation of signal transducer and activator transcription factor 1 (STAT1) is a key response in the type I interferon (IFN) cascade. We developed novel flow cytometric assay for phosphotyrosine-STAT1 (p-STAT1) to rapidly monitor vivo IFN signaling. Mouse blood stimulated with mouse IFN-α was hemolyzed lysis buffer place lymphocyte purification, permeabilized methanol, stained an Alexa Fluor 488-conjugated anti-p-STAT1 antibody. The cells were also phycoerythrin (PE)-conjugated anti-CD45 antibody eliminating debris (CD45-negative) from leukocytes (CD45-positive), PE covalently linked cyanin 5-conjugated anti-Gr-1 separating lymphocytes (Gr-1-negative) granulocytes (Gr-1-positive). When whole treated IFN-α, 488 intensity increased, reaching peak within 1 h, this increase statistically significant at concentrations 100 U/mL higher. administered intravenously mice, 1 h returning baseline 18 h, dose-dependent, increases seen doses 1000 U/body kinetics dose–responses p-STAT1 levels spleen, lung, liver similar those lymphocytes. This new peripheral will be useful examining signaling monitoring tissue vivo.

参考文章(29)
Weiss K, Safety profile of interferon-alpha therapy. Seminars in Oncology. ,vol. 25, pp. 9- 13 ,(1998)
Douglas S. Goodin, Interferon- β Therapy in Multiple Sclerosis Drugs. ,vol. 61, pp. 1693- 1703 ,(2001) , 10.2165/00003495-200161120-00001
D Festi, L Sandri, G Mazzella, E Roda, T Sacco, T Staniscia, S Capodicasa, A Vestito, A Colecchia, Safety of interferon beta treatment for chronic HCV hepatitis. World Journal of Gastroenterology. ,vol. 10, pp. 12- 16 ,(2004) , 10.3748/WJG.V10.I1.12
Charles A. Dinarello, Ronald B. Herberman, Tattanahalli L. Nagabhushan, Lawrence M. Pfeffer, Ronald Bordens, Mark R. Walter, Sidney Pestka, Ernest C. Borden, Bryan R. G. Williams, Paul P. Trotta, Biological Properties of Recombinant α-Interferons: 40th Anniversary of the Discovery of Interferons Cancer Research. ,vol. 58, pp. 2489- 2499 ,(1998)
Shiro Tochizawa, Seiji Akamatsu, Yoshihiro Sugiyama, Masahiro Muraguchi, Yasukazu Ohmoto, Yukihisa Ono, Hiroshi Ishikawa, Akira Tanigami, Takumi Sumida, Toyoki Mori, A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets. Journal of Pharmacological and Toxicological Methods. ,vol. 50, pp. 59- 66 ,(2004) , 10.1016/J.VASCN.2004.02.003
Svetlana Radaeva, Barbara Jaruga, Feng Hong, Won–Ho Kim, Saijun Fan, Hongbo Cai, Stephen Strom, Youhua Liu, Osama El–Assal, Bin Gao, Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes Gastroenterology. ,vol. 122, pp. 1020- 1034 ,(2002) , 10.1053/GAST.2002.32388
Stefan A. Dupont, Susan Goelz, Jaya Goyal, Marie Green, Mechanisms for Regulation of Cellular Responsiveness to Human IFN-β1a Journal of Interferon and Cytokine Research. ,vol. 22, pp. 491- 501 ,(2002) , 10.1089/10799900252952280
Lawrence M. Pfeffer, Leela Basu, Susan R. Pfeffer, Chuan He Yang, Aruna Murti, Dean Russell-Harde, Ed Croze, The Short Form of the Interferon α/β Receptor Chain 2 Acts as a Dominant Negative for Type I Interferon Action Journal of Biological Chemistry. ,vol. 272, pp. 11002- 11005 ,(1997) , 10.1074/JBC.272.17.11002
Matthew P. Hardy, Catherine M. Owczarek, Suzana Trajanovska, Xiang Liu, Ismail Kola, Paul J. Hertzog, The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties Blood. ,vol. 97, pp. 473- 482 ,(2001) , 10.1182/BLOOD.V97.2.473
T. Charis Wagner, Sharlene Velichko, Steven K. Chesney, Sandra Biroc, Dean Harde, David Vogel, Ed Croze, Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors International Journal of Cancer. ,vol. 111, pp. 32- 42 ,(2004) , 10.1002/IJC.20236